维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Daniel D.Leary"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment显示文摘The patient population suffering from pancreatic ductal adenocarcinoma(PDAC)presents,as a whole,with a high degree of molecular tumor heterogeneity.The heterogeneity of PDAC tumor composition has complicated treatment and stalled success in clinical trials.Current in vitro techniques insufficiently replicate the intricate stromal components of PDAC tumor microenvironments(TMEs)and fail to model a given tumor's unique genetic phenotype.The development of patient-derived organoids(PDOs)has opened the door for improved personalized medicine since PDOs are derived directly from patient tumors,thus preserving the tumors'unique behaviors and genetic phenotypes.This study developed a tumor-chip device engineered to mimic the PDAC TME by incorporating PDOs and stromal cells,specifically pancreatic stellate cells and macrophages.Establishing PDOs in a multicellular microfluidic chip device prolongs cellular function and longevity and successfully establishes a complex organotypic tumor environment that incorporates desmoplastic stroma and immune cells.When primary cancer cells in monoculture were subjected to stroma-depleting agents,there was no effect on cancer cell viability.However,targeting stroma in our tumor-chip model resulted in a significant increase in the chemotherapy effect on cancer cells,thus validating the use of this tumor-chip device for drug testing.	Muhammad R.Haque Caitlin R.Wessel Daniel D.Leary Chengyao Wang Abhinav Bhushan Faraz Bishehsari	2022	Microsystems & Nanoengineering2022，8，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费